News & Events

  • March 21, 2014

    Client Update:  New York City Earned Sick Time Act - Effective April 1, 2014

    Beginning April 1, the law, passed originally last summer, and significantly expanded by the City Council this past February, requires private-sector employers with 5 or more employees in New York City to offer at least 40 hours of annual paid sick leave to each employee. Employers with fewer than 5 employees in the city will be required to offer at least 40 hours of unpaid sick leave to each employee per year.  Click here to read some highlights of the new requirement.

  • March 21, 2014

    IsoRay, Inc. announced the completion of a registered direct offering in the amount of $14,675,180. EG&S acted as counsel to the placement agent.

  • March 21, 2014

    RiceBran Technologies completed a private placement in the amount of $4.9 million. EG&S acted as counsel to the placement agent.

  • March 14, 2014

    pSivida Corp. announced the closing of their Registered Direct offering in the amount of $7,000,000. EG&S acted as counsel to the Placement Agent.

  • March 13, 2014

    University General Health Systems, Inc. announced the closing of their PIPE offering in the amount of $1,232,000.  EG&S acted as counsel to the Investor.

  • March 13, 2014

    Anavex Life Sciences Corp. completed a private placement in the amount of $10 million. EG&S acted as counsel to the placement agent.

  • March 13, 2014

    Galmed Pharmaceuticals Ltd. completed its initial public offering in the amount of $39,700,000. EG&S acted as counsel to the underwriter.

  • March 12, 2014

    Saul H. Finkelstein, a member of the Firm, was invited to speak at C4CM's audio conference titled "GC Guide to Drafting, Updating & Negotiating Confidentiality Agreements for Corporate Mergers/Acquisitions."

  • March 07, 2014

    Mandalay Digital Group, Inc. announced the closing of their Underwritten offering in the amount of $16,273,207.  EG&S acted as counsel to the Underwriter.

  • February 26, 2014

    Oculus Innovative Sciences, Inc. announced the closing of their Registered Direct offering in the amount of $1,351,860.  EG&S acted as counsel to the Placement Agent.

  • February 24, 2014

    Benitec Biopharma Limited completed a private placement in the amount of AUD $31.5 million. EG&S acted as counsel to the placement agent.

  • February 21, 2014

    IZEA, Inc. announced the closing of their PIPE offering in the amount of $12,000,000.  EG&S acted as counsel to the Investor.

  • February 18, 2014

    Oxigene Inc. announced the closing of their Registered Direct offering in the amount of $11,999,996.  EG&S acted as counsel to the Placement Agent.

  • February 18, 2014

    DARA BioSciences, Inc. announced the closing of their Registered Direct offering in the amount of $5,990,375.  EG&S acted as counsel to the Placement Agent.

  • February 13, 2014

    BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced the closing of a $60 million registered direct financing with institutional investors. EG&S acted as counsel to BDSI.

  • February 13, 2014

    LabStyle Innovations Corp.‎ (OTCQB:DRIO) announced the pricing of a $4.1 million private investment in public equity (PIPE) offering to institutional and accredited investors. EG&S acted as counsel to LabStyle.

  • February 12, 2014

    Uranium Resources, Inc. announced the closing of their Registered Direct offering in the amount of $10,296,000.  EG&S acted as counsel to the Investor.

  • February 07, 2014

    ARCA Biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $8,697,587.  EG&S acted as counsel to the Placement Agent.

  • February 05, 2014

    MELA Sciences Inc. announced the closing of their PIPE offering in the amount of $12,300,000.  EG&S acted as counsel to the Placement Agent.

  • February 04, 2014

    UQM Technologies, Inc. announced the closing of their Registered Direct offering in the amount of $5,300,013.  EG&S acted as counsel to the Placement Agent.

  • January 31, 2014

    Vycor Medical, Inc. announced the closing of their PIPE offering in the amount of $1,784,200.  EG&S acted as counsel to the Placement Agent.

  • January 30, 2014

    ThermoGenesis Corp. announced the closing of their PIPE offering in the amount of $6,673,600.  EG&S acted as counsel to the Placement Agent.

  • January 29, 2014

    Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for 2013.

    Click here to view the rankings

  • January 28, 2014

    CUR Media, Inc. (OTCBB:CURM) has completed the acquisition of Raditaz, LLC, a Connecticut Limited Liability Company and a simultaneous $4.08M in private placement offering.  EG&S acted as counsel to Raditaz.

  • January 27, 2014

    MagneGas Corporation announced the closing of their Registered Direct offering in the amount of $4,000,000. EG&S acted as counsel to the Investor.